DeepMed Research

JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)

Phase 2

Recruiting

Conditions: Long COVID-19
Long COVID
Hypersomnia

Interventions: Drug: Modafinil Placebo
Drug: Modafinil
Drug: Solriamfetol
Drug: Solriamfetol Placebo

First Posted Date: 2024-05-08

Last Posted Date: 2025-04-23

Lead Sponsor: Duke University

Target Recruit Count: 474

Registration Number: NCT06404099

Locations: 🇺🇸
All sites listed under NCT06404086, Durham, North Carolina, United States

RECOVER-SLEEP: Platform Protocol

Phase 2

Recruiting

Conditions: Long COVID
Long COVID-19
Hypersomnia
Sleep Disturbance

Interventions: Drug: Melatonin
Drug: Modafinil
Drug: Melantonin Placebo
Drug: Modafinil Placebo
Device: Tailored lighting (TL) Active
Drug: Solriamfetol
Device: Tailored lighting (TL) Placebo
Drug: Solriamfetol Placebo

First Posted Date: 2024-05-08

Last Posted Date: 2025-04-23

Lead Sponsor: Duke University

Target Recruit Count: 1074

Registration Number: NCT06404086

Locations: 🇺🇸
Banner University Medical Center Phoenix, Phoenix, Arizona, United States
🇺🇸
University of Arizona Banner Medical Center, Tucson, Arizona, United States
🇺🇸
University of California San Francisco General Hospital, San Francisco, California, United States

and more 42 locations

RECOVER-ENERGIZE Platform Protocol

Not Applicable

Recruiting

Conditions: Long Covid-19
Long Covid19
Long COVID

Interventions: Behavioral: Personalized Cardiopulmonary Rehabilitation
Behavioral: Structured Pacing
Other: Usual Care
Other: Education

First Posted Date: 2024-05-08

Last Posted Date: 2025-05-21

Lead Sponsor: Duke University

Target Recruit Count: 660

Registration Number: NCT06404047

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Banner University Medical Center Phoenix, Phoenix, Arizona, United States
🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

and more 39 locations

RECOVER-ENERGIZE Platform Protocol_Appendix A (Exercise Intolerance)

Not Applicable

Recruiting

Conditions: Long COVID
Long Covid19
Long Covid-19

Interventions: Behavioral: Personalized Cardiopulmonary Rehabilitation
Other: Education

First Posted Date: 2024-05-08

Last Posted Date: 2025-05-20

Lead Sponsor: Duke University

Target Recruit Count: 360

Registration Number: NCT06404060

Locations: 🇺🇸
All sites listed under NCT06404047, Durham, North Carolina, United States

RECOVER-ENERGIZE Platform Protocol_Appendix B (Structured Pacing (PEM))

Not Applicable

Active, not recruiting

Conditions: Long Covid19
Long COVID
Long Covid-19

Interventions: Other: Usual Care
Behavioral: Structured Pacing

First Posted Date: 2024-05-08

Last Posted Date: 2025-05-23

Lead Sponsor: Duke University

Target Recruit Count: 300

Registration Number: NCT06404073

Locations: 🇺🇸
All sites listed under NCT06404047, Durham, North Carolina, United States

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

Recruiting

Conditions: Lung Transplant; Infection or Inflammation
Lung Transplant; Complications
Lung Transplant Failure
Lung Transplant Rejection

First Posted Date: 2024-05-03

Last Posted Date: 2024-10-08

Lead Sponsor: Duke University

Target Recruit Count: 2600

Registration Number: NCT06399302

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸
University of California at San Francisco, San Francisco, California, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

ACT for Infertility: Case Series

Not Applicable

Active, not recruiting

Conditions: Psychological Distress
Acceptance and Commitment Therapy
Infertility
Psychological Flexibility

Interventions: Behavioral: Acceptance and Commitment Therapy

First Posted Date: 2024-04-29

Last Posted Date: 2025-05-18

Lead Sponsor: Duke University

Target Recruit Count: 9

Registration Number: NCT06388044

Locations: 🇺🇸
Duke North Pavilion, Durham, North Carolina, United States

TOP 2301: Neoadjuvant Chemo for NSCLC

Phase 2

Recruiting

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Cemiplimab
Drug: Alirocumab
Drug: Chemotherapy

First Posted Date: 2024-04-26

Last Posted Date: 2025-03-25

Lead Sponsor: Duke University

Target Recruit Count: 126

Registration Number: NCT06385262

Locations: 🇺🇸
Duke University, Durham, North Carolina, United States

Family Involvement Hospital Ethnography

Recruiting

Conditions: Dementia

First Posted Date: 2024-04-19

Last Posted Date: 2024-05-24

Lead Sponsor: Duke University

Target Recruit Count: 40

Registration Number: NCT06374992

Locations: 🇺🇸
Duke Regional Hospital, Durham, North Carolina, United States

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors

Not Applicable

Not yet recruiting

Conditions: Sarcoma
Lymphoma
Colorectal Cancer
Testicular Cancer
Cancer
Breast Cancer

Interventions: Behavioral: AYA Educational Information
Behavioral: AYA STEPS

First Posted Date: 2024-04-17

Last Posted Date: 2025-04-30

Lead Sponsor: Duke University

Target Recruit Count: 260

Registration Number: NCT06371768

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy